在癌症中,ABC蛋白与多药耐药性的关联
Andrezza Viviany Lourenço Marques1, Bruna Estelita Ruginsk1, Larissa de Oliveira Prado1
1Graduate Program in Pharmaceutical Sciences, Laboratory of Cancer Drug Resistance, Federal University of Parana, Curitiba, Paraná, Brazil.
Biochimica et biophysica acta. Molecular cell research
|November 21, 2024
概括
癌症中的多药性耐药性 (MDR) 通常是由ATP结合盒 (ABC) 蛋白质引起的. 这次审查将20种ABC蛋白与MDR联系起来,有助于新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多药耐药性 (MDR) 是癌症治疗的一个主要障碍,特别是转移性癌症.
- 过度表达ATP结合盒 (ABC) 蛋白质是导致MDR的一个关键机制.
研究的目的:
- 审查并确定ABC蛋白过度表达和癌症中MDR之间的相关性.
- 为了确定特定的ABC蛋白及其相关的抗癌药物参与MDR.
主要方法:
- 在体外和临床研究的文献综述.
- 概述ABC蛋白质的七个子家族及其定位.
- 鉴定了与MDR相关的20种ABC蛋白和29种药物作为关键载体的基质.
主要成果:
- 有20种ABC蛋白 (ABCA1-3,ABCA7,ABCB1-2,ABCB4-6,ABCC1-5,ABCC10-11,ABCE1,ABCF2,ABCG1,ABCG2) 与MDR有关,这些蛋白质可以与MDR相关联.
- 29种抗癌药物是ABCB1,ABCC1或ABCG2.2的基质.
- 通常用于乳腺癌,肺癌和白血病的化疗药物受到ABC载体介导的MDR的影响.
结论:
- 在各种癌症中,ABC蛋白在MDR中发挥着关键作用.
- 了解ABC输送器功能对于开发有效的癌症治疗非常重要.
- 向ABC蛋白可能会提高治疗效率并改善患者的治疗结果.
相关概念视频
ABC Transporters: Exporter
4.2K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.2K
ABC Transporters: Importer
2.7K
ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
2.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Carrier-Mediated Transport
310
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
310


